GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » Change In Receivables

SC Ropharma (BSE:RPH) Change In Receivables : lei-20 Mil (TTM As of Jun. 2024)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma Change In Receivables?

SC Ropharma's change in receivables for the quarter that ended in Jun. 2024 was lei-17 Mil. It means SC Ropharma's Accounts Receivable increased by lei17 Mil from Dec. 2023 to Jun. 2024 .

SC Ropharma's change in receivables for the fiscal year that ended in Dec. 2023 was lei5 Mil. It means SC Ropharma's Accounts Receivable declined by lei5 Mil from Dec. 2022 to Dec. 2023 .

SC Ropharma's Accounts Receivable for the quarter that ended in Jun. 2024 was lei261 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SC Ropharma's Days Sales Outstanding for the six months ended in Jun. 2024 was 84.85.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SC Ropharma's liquidation value for the six months ended in Jun. 2024 was lei-300 Mil.


SC Ropharma Change In Receivables Historical Data

The historical data trend for SC Ropharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma Change In Receivables Chart

SC Ropharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.48 13.38 -4.22 -45.45 4.90

SC Ropharma Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.30 -38.15 7.90 -3.00 -16.56

SC Ropharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was lei-20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SC Ropharma  (BSE:RPH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SC Ropharma's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=260.612/560.511*91
=84.85

2. In Ben Graham's calculation of liquidation value, SC Ropharma's accounts receivable are only considered to be worth 75% of book value:

SC Ropharma's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=32.477-632.358+0.75 * 260.612+0.5 * 209.308
=-300

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SC Ropharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of SC Ropharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma Business Description

Traded in Other Exchanges
N/A
Address
Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma Headlines

No Headlines